“The Latest Clinical Trial Results and Future Treatment for Alzheimer’s”

Presented in partnership with Barrington Area Council on Aging (BACOA). Program Benefactor: Hart Dental.

Alzheimer’s is a devastating disease for both individuals and their families. Join us for an insightful afternoon of learning with Keith Fargo, Ph.D., the director of Scientific Programs & Outreach at the Alzheimer’s Association. He will discuss exciting new clinical trial results that may impact the future treatment of this condition in 2020 and beyond. A panel of Chicago-area researchers will briefly discuss their own research areas and answer audience questions.

Joining Dr. Fargo will be Daniel Lee (Northwestern University), Grace “Beth” Stutzmann (Rosalind Franklin University), and Hemraj Dodiya (University of Chicago)

Dr. Fargo leads research programs and initiatives to accelerate the Association’s vision of a world without Alzheimer’s. He works alongside a committee of expert researchers to develop scientific programming for the Alzheimer’s Association International Conference (AAIC), the largest and most influential international meeting dedicated to advancing dementia science. Annually, AAIC offers over 2,400 poster sessions and more than 100 podium presentations on basic science, risk factors, diagnosis, causes, risk factors, and potential methods of treatment and prevention to nearly 6,000 of the world’s leading researchers.

Dr. Fargo directs the Association’s efforts to build participation in Alzheimer’s disease research studies as a critical component of advancement in the field. He manages the Association’s role in recruiting participants for the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS), a cutting-edge project that explores the development of early-onset Alzheimer’s disease and how it compares to the more common late-onset Alzheimer’s disease. Dr. Fargo also ensures the quality, responsiveness and promotion of Alzheimer’s Association TrialMatch®, a free clinical studies matching service that connects individuals with Alzheimer’s, caregivers and healthy volunteers to hundreds of current studies.

Dr. Fargo received his Ph.D. from Indiana University and completed a postdoctoral fellowship at Loyola University Stritch School of Medicine. Before joining the Alzheimer’s Association, Dr. Fargo held positions as a research scientist at the Edward Hines, Jr. VA Hospital Rehabilitation Research & Development Program and as an assistant research professor at the Loyola University Chicago Department of Molecular Pharmacology & Therapeutics.